148 related articles for article (PubMed ID: 2903400)
1. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.
Hedner U; Glazer S; Pingel K; Alberts KA; Blombäck M; Schulman S; Johnsson H
Lancet; 1988 Nov; 2(8621):1193. PubMed ID: 2903400
[No Abstract] [Full Text] [Related]
2. Recombinant factor VIIa (r-FVIIa) in haemophilia management.
Rice KM; Savidge GF
Transfus Sci; 1996 Sep; 17(3):339-40. PubMed ID: 10184611
[No Abstract] [Full Text] [Related]
3. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.
Young G; McDaniel M; Nugent DJ
Haemophilia; 2005 May; 11(3):203-7. PubMed ID: 15876264
[TBL] [Abstract][Full Text] [Related]
4. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
[No Abstract] [Full Text] [Related]
5. Trial of haemophilia treatment for intracerebral haemorrhage.
Lowe R
Lancet Neurol; 2004 Aug; 3(8):448. PubMed ID: 15303268
[No Abstract] [Full Text] [Related]
6. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
Tcheng WY; Donkin J; Konzal S; Wong WY
Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
[TBL] [Abstract][Full Text] [Related]
7. The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency.
González-Boullosa R; Ocampo-Martínez R; Alarcón-Martín MJ; Suárez-Rodríguez M; Domínguez-Viguera L; González-Fajo G
Haemophilia; 2005 Mar; 11(2):167-70. PubMed ID: 15810919
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Baudo F; de Cataldo F; Gaidano G;
Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.
Guillet B; Pinganaud C; Proulle V; Dreyfus M; Lambert T
Thromb Haemost; 2002 Oct; 88(4):698-9. PubMed ID: 12362252
[No Abstract] [Full Text] [Related]
10. Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Ng HJ; Lee LH
Ann Acad Med Singap; 2002 Mar; 31(2):241-4. PubMed ID: 11957567
[TBL] [Abstract][Full Text] [Related]
11. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
Hedner U
Semin Thromb Hemost; 2000; 26(4):363-6. PubMed ID: 11092209
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa: a general hemostatic agent? Yes.
Roberts HR
J Thromb Haemost; 2004 Oct; 2(10):1691-4. PubMed ID: 15456475
[No Abstract] [Full Text] [Related]
13. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
Laguna P; Klukowska A
Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa: a general hemostatic agent? Not yet.
Levi M
J Thromb Haemost; 2004 Oct; 2(10):1695-7. PubMed ID: 15456476
[No Abstract] [Full Text] [Related]
15. rFVIIa (Novoseven): the new panacea?
Ickx BE
Acta Anaesthesiol Belg; 2003; 54(4):333-5. PubMed ID: 14719355
[No Abstract] [Full Text] [Related]
16. Some recent developments regarding arthropathy and inhibitors in haemophilia.
Rodriguez-Merchan EC
Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
[TBL] [Abstract][Full Text] [Related]
17. Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.
Hedner U
J Thromb Haemost; 2006 Nov; 4(11):2498-500. PubMed ID: 16907841
[No Abstract] [Full Text] [Related]
18. Recombinant FVIIa.
Hedner U
Vox Sang; 2004 Jul; 87 Suppl 2():25-8. PubMed ID: 15209873
[No Abstract] [Full Text] [Related]
19. Prevention of haemophilic arthropathy in haemophilic children with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2008 Nov; 14 Suppl 6():1-3. PubMed ID: 19134025
[TBL] [Abstract][Full Text] [Related]
20. Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors.
Ewenstein BM; Wong WY; Schoppmann A
Haemophilia; 2010 Jan; 16(1):179-80. PubMed ID: 19702885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
